Annual General Meeting to be held on Tuesday April 29 2025 and 2024 Universal Registration Document
Annual General Meeting to be held on Tuesday April 29 2025 and 2024 Universal Registration Document
L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 29 April 2025 and the 2024 Universal Registration Document.
L’Oréal Groupe announces strategic research partnership with tru diagnostic to advance beauty and longevity science, through unlocking discoveries in Epigenomics.
L’Oréal Groupe announces strategic research partnership with tru diagnostic to advance beauty and longevity science, through unlocking discoveries in Epigenomics.
L’Oréal Groupe is thrilled to announce a strategic research and development partnership with Tru Diagnostic, the foremost authority in epigenomics(1) testing. This collaboration aims to explore the connection between beauty indicators and changes in epigenomic markers, paving the way for groundbreaking advancements in the field of longevity.
L’Oréal Groupe achieves ninth consecutive CDP triple ‘A’ score
L’Oréal Groupe achieves ninth consecutive CDP triple ‘A’ score
L’Oréal Groupe achieves ninth consecutive CDP triple ‘A’ score, demonstrating its commitment to leadership and transparency in climate, forests and water security
Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’Oréal
Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’Oréal
L’Oréal announces today that it has agreed to sell approximately 29.6 million of Sanofi shares to Sanofi for €101.5 per share, for a total consideration of €3 billion.